drugset / Trial / NCT02178657

Intra-arterial Bone-marrow Mononuclear Cells Infusion for Acute Ischemic Stroke

NCT02178657

Phase 2 Completed 76 enrolled Andalusian Initiative for Advanced Therapies
RandomizedParallel-groupSingle-blindTreatment

Summary

This trial aims to test that intra-arterial injection of autologous bone marrow mononuclear cells in acute ischemic stroke patients is safe and improves neurological outcomes.

Timeline

Start
2015-04
Primary completion
2021-10-27
Completion
2023-04-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject bone marrow mononuclear cells Cell therapy 2e+06 cells/kg Other
Subject bone marrow mononuclear cells Cell therapy 5e+06 cells/kg Other

Indications